Tang, W.; Chang, Z.W.; Goh, Y.S.; Tan, Y.J.; Hor, P.X.; Loh, C.Y.; Lye, D.C.; Young, B.E.; Ng, L.F.P.; Tay, M.Z.;
et al. SARS-CoV-2 mRNA Vaccines Induce Cross-Reactive Antibodies to NL63 Coronavirus but Do Not Boost Pre-Existing Immunity Anti-NL63 Antibody Responses. Vaccines 2025, 13, 268.
https://doi.org/10.3390/vaccines13030268
AMA Style
Tang W, Chang ZW, Goh YS, Tan YJ, Hor PX, Loh CY, Lye DC, Young BE, Ng LFP, Tay MZ,
et al. SARS-CoV-2 mRNA Vaccines Induce Cross-Reactive Antibodies to NL63 Coronavirus but Do Not Boost Pre-Existing Immunity Anti-NL63 Antibody Responses. Vaccines. 2025; 13(3):268.
https://doi.org/10.3390/vaccines13030268
Chicago/Turabian Style
Tang, Weiyi, Zi Wei Chang, Yun Shan Goh, Yong Jie Tan, Pei Xiang Hor, Chiew Yee Loh, David C. Lye, Barnaby E. Young, Lisa F. P. Ng, Matthew Zirui Tay,
and et al. 2025. "SARS-CoV-2 mRNA Vaccines Induce Cross-Reactive Antibodies to NL63 Coronavirus but Do Not Boost Pre-Existing Immunity Anti-NL63 Antibody Responses" Vaccines 13, no. 3: 268.
https://doi.org/10.3390/vaccines13030268
APA Style
Tang, W., Chang, Z. W., Goh, Y. S., Tan, Y. J., Hor, P. X., Loh, C. Y., Lye, D. C., Young, B. E., Ng, L. F. P., Tay, M. Z., Rénia, L., on behalf of the COVID-19 Cohort Study Group, NCID Study Group, & COVID Clinicians’ Group.
(2025). SARS-CoV-2 mRNA Vaccines Induce Cross-Reactive Antibodies to NL63 Coronavirus but Do Not Boost Pre-Existing Immunity Anti-NL63 Antibody Responses. Vaccines, 13(3), 268.
https://doi.org/10.3390/vaccines13030268
